PAM
WST icon

Peninsula Asset Management’s West Pharmaceutical WST Stock Holding History

Peninsula Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Buy
7,449
+700
+10% +$214K 1.28% 27
2026
Q1 		$1.69M Sell
6,749
-205
-3% -$51K 0.86% 31
2025
Q4 		$1.91M Sell
6,954
-1,827
-21% -$500K 0.98% 30
2025
Q3 		$2.3M Buy
8,781
+58
+0.7% +$14.1K 1.18% 29
2025
Q2 		$1.91M Buy
8,723
+190
+2% +$40.6K 1.01% 31
2025
Q1 		$1.91M Sell
8,533
-85
-1% -$23.4K 1.06% 30
2024
Q4 		$2.82M Sell
8,618
-1,075
-11% -$338K 1.5% 25
2024
Q3 		$2.91M Buy
9,693
+15
+0.2% +$4.59K 1.47% 26
2024
Q2 		$3.19M Buy
9,678
+93
+1% +$32.9K 1.75% 24
2024
Q1 		$3.79M Buy
9,585
+5
+0.1% +$1.85K 2.03% 23
2023
Q4 		$3.37M Buy
9,580
+35
+0.4% +$12.4K 1.97% 21
2023
Q3 		$3.58M Hold
9,545
– – 2.26% 18
2023
Q2 		$3.65M Buy
9,545
+3,187
+50% +$1.14M 2.15% 19
2023
Q1 		$2.2M Buy
+6,358
New +$1.86M 1.38% 31

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Peninsula Asset Management's WST Position: Q2 2026 in Review

Peninsula Asset Management increased its West Pharmaceutical (WST) stake by 10% in Q2 2026, buying an estimated $214K and bringing the position to 7,449 shares worth $2.67M. The position accounts for 1.28% of the portfolio, ranked #27.

Peninsula Asset Management first reported a position in WST in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.79M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Peninsula Asset Management held 7,449 shares of West Pharmaceutical worth $2.67M as of Q2 2026.
  • Peninsula Asset Management bought 700 West Pharmaceutical shares in Q2 2026, an estimated $214K.
  • West Pharmaceutical made up 1.28% of Peninsula Asset Management's portfolio in Q2 2026, its #27 holding.
  • Peninsula Asset Management first reported a position in West Pharmaceutical in Q1 2023 and has held it in 14 quarters since.
  • Peninsula Asset Management's West Pharmaceutical position peaked at $3.79M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Peninsula Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.